Valuation (3%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -28.73 | N/A |
| PEG Ratio (TTM) | -0.29 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | 7.82 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | -16.22 | N/A |
| Price to 5YR AVG FCF Ratio | -19.30 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -26.51% | N/A |
| ROE (TTM) | -23.51% | N/A |
| Net Profit Margin (TTM) | N/A | N/A |
| ROIC 5YR AVG | -76.13% | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -42,459.96% | -199.12% | -109.93% |
| Revenue | N/A | N/A | N/A |
| Net Income | -104,003.96% | -208.24% | -115.42% |
| Cash Flow | 2,565,574.17% | -225.96% | -130.55% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 41.92 | N/A |
| Quick Ratio (TTM) | 41.92 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -0.01 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.59% | N/A |